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AbsTRACT
This article reinvigorates a key question in publication 
ethics: Is there research that it is permissible to conduct 
but that ought not to be published? The article raises 
the question in relation to two recent medical studies. It 
is argued (1) that the publication of these studies may 
cause significant harm to individuals, (2) that editors 
of medical journals have a moral responsibility for such 
harm, (3) that denial of publication is inadequate as 
an instrument to fulfil this moral responsibility and (4) 
that internationally acknowledged publication ethics 
codes should incorporate this aspect of editors’ moral 
responsibility.
InTRoduCTIon 
A recent Danish study found that symptoms of a 
widespread chronic disease could be alleviated by 
the use of antibiotics. Getting the study published 
turned out to be difficult. At least one reviewer 
from a reputable journal noted that the study could 
influence the clinical practice in an undesirable way 
by leading to an increased use of antibiotics and 
thus ultimately adding to the problem of micro-
bial multiresistance. The BMJ recently published 
an article suggesting that side-effects of statins may 
outweigh health benefits in patients at low and 
intermediate risk of cardiovascular disease.1 The 
article sparked intense debate2—not least in the 
mass media3–7—and one study suggests that as many 
as 200 000 people in the UK have stopped taking 
statins as a consequence of the media coverage, 
potentially leading to 2000 cardiovascular events in 
the future.8–10
The two cases reinvigorate but also add important 
new aspects to a contested topic in publication 
ethics, namely whether there is medical research 
that is permissible to conduct but that ought not to 
be published.
This question is not a new one.11 Previous consid-
erations have, however, focused almost exclusively 
on cases in which medical research may be used 
for biological warfare and bioterrorism.11–14 The 
threat of bioterrorism led a group of journal editors 
and authors to issue a statement in Science and 
Nature in 2003. In this statement, they recognised 
that the potential harm of publication occasion-
ally may outweigh the societal benefits and that in 
such cases, ‘the paper should be modified, or not 
be published’.15 However, the moral responsibility 
of editors and reviewers to consider the poten-
tial harmful effects of publishing research is not 
included in two of the main publication ethics codes, 
the Committee on Publication Ethics’ (COPE) 
Code of Conduct and the International Committee 
of Medical Journal Editors’ (ICMJE) Recommen-
dations.16 17 The World Association of Medical 
Editors’ (WAME) states that medical editors, 
‘should also take into account whether studies are 
ethical and whether their publication might cause 
harm to readers or to the public interest’,18 but this 
requirement only figures in their policy statement 
entitled ‘Geopolitical Intrusion on Editorial Deci-
sions’ dealing with editorial influence from ‘poli-
cies of governments or other agencies outside of the 
journal itself ’ and therefore seems likely to be inter-
preted as concerning only the threat of biological 
warfare and bioterrorism.
In this article, it is argued (1) that the publica-
tion of the Danish and UK studies may cause signif-
icant harm to individuals, (2) that medical journal 
editors have a moral responsibility for the poten-
tial harmful effects of publishing research, (3) that 
denial of publication is inadequate as an instrument 
for fulfilling this moral responsibility and (4) that 
therefore internationally acknowledged publication 
ethics codes should provide editors with a firm basis 
for evaluating and mitigating the potential effects 
of publishing medical research in general. The 
article deals solely with the publication of medical 
research simply because this is a field of research 
that is already regulated by a number of interna-
tional codes. However, the points made certainly 
also apply to other fields of research.
ReseARCh eThICs And publICATIon eThICs
Research ethics is concerned with the ethical legit-
imacy of conducting research. It provides a set of 
moral reasons for permitting or not permitting the 
conducting of certain types of research. In practice, 
the ethical principles and values playing a regula-
tory role for conducting healthcare research are laid 
out in the Helsinki and Taipei declarations and the 
Oviedo Convention.19–21
Publication ethics is concerned with the ethics 
of publishing research. It provides a set of moral 
reasons for permitting or not permitting the 
publishing of certain types of research. In practice, 
publication of medical research is guided by inter-
national codes such as the COPE Code of Conduct 
for Journal Editors, ICMJE Recommendations and 
the WAME Professionalism Code of Conduct with 
its supplementary recommendations.16 17 22
The principles of research ethics and the prin-
ciples of publication ethics may lead to different 
conclusions in relation to the same research. 
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Table 1 Relations between Research and publication ethics 
Domain
 
Publication
ethics
Research that ought 
to be published
Research that ought 
not to be published
Research
ethics
Research that is 
permissible to 
conduct
Box 1 Box 4
Research that is 
not permissible to 
conduct
Box 2 Box 3
Table 1 shows the possible combinations of views concerning the 
ethical legitimacy of conducting and publishing a certain type of 
research.
That there are cases of research that fit in box 1 and box 3 
seems straightforward.
Box 2 has received some attention in the literature. It has been 
argued that although certain types of research are not permis-
sible—because they cause harm to research participants or 
violate requirements of informed consent—the results of such 
research may be of such importance for public health that it 
should be published if it has been conducted.23 24
Box 4 is the object of this article. Clearly, otherwise valuable 
research may fit in this category if the reporting of this research 
violates principles of for example, scientific integrity. Research 
may also, however, fit in this category because of the potential 
harmful effects following publication of such research. Research 
that may be used for bioterrorism could be one such example. 
The Danish and UK studies raise the question whether research 
may fit into this category because the publishing of this research 
may have harmful effects other than those associated with 
bioterrorism.
The moRAl ResponsIbIlITy of edIToRs foR The hARmful 
effeCTs of publIshIng ReseARCh
The harmful effects of publishing research
If we have moral reasons to consider rejecting publication of 
research that may be used for bioterrorism, we certainly also 
have moral reasons to consider rejecting publication of the 
Danish and UK studies. Thus, they are similar to research posing 
a security/safety risk in at least two ways:
1. They may lead to significant harmful effects to a significant 
number of people.
2. Publishing the research significantly increases the likelihood 
of these harmful effects.
The Danish study may lead to an increased use of antibiotics 
ultimately increasing the problem of microbial multiresistance. 
The UK study could lead to increased numbers cardiovascular 
events due to undertreatment or due to patient incompliance. 
In both cases, the harmful effects are the potential outcome of 
changes in clinical practice. In the latter case, the harmful effects 
could also follow unwarranted changes in patient behaviour.
As in the case of research that may be used for bioterrorism, 
it is the publishing of these studies in a scientific journal that 
significantly increases the likelihood of the harmful effects. 
Isolated research into the effects of antibiotics on a chronic 
disease and the effects of statins on levels of cholesterol without 
exposure in scientific journals and mass media seem unlikely to 
really affect clinical practice and patient behaviour.
It may be objected that publication does not make such effects 
likely in absolute terms. However, the publishing of an article on 
the possibility of artificially synthesising a live poliovirus does 
not make bioterrorism likely in absolute terms. It still requires 
a number of persons with significant expertise, access to appro-
priate facilities and funding and arguably also limited morality. 
Likely or not, there are important differences between this type 
of study and the Danish and UK studies. Differences that seem to 
make the harmful effects of publishing the latter studies consid-
erably more likely:
 ► They are of direct relevance to the clinical practice.
 ► They hold promise of novel and significant healthcare 
benefits.
 ► These potential health benefits are in the interest of large 
groups of patients/people.
These features will make the publishing of these studies attract 
the attention of researchers and healthcare professionals. They 
will also, however, increase the likelihood of exposure in the 
mass media (the Danish and UK study both received attention 
in the mass media), which in turn may come to fuel a clinical, 
political and public demand to further develop and implement 
these new treatment options and findings into healthcare policy 
and practice or it may simply lead to changes in patient behav-
iour, all of which pave the way for the potentially harmful effects 
suggested above.
The moral responsibility of editors
An adequate account of the moral responsibility of journal 
editors should make editors morally accountable for the harmful 
effects of publishing research for at least two reasons:
1. Editors make the decision to publish research that may have 
harmful effects.
2. Editors are in a position to foresee the potential harmful 
effects.
For an agent to be morally responsible for certain harmful 
effects, the agent must be the cause of these effects. Editors 
make the decision on whether or not to publish research. This 
means that they influence whether or not the harmful effects of 
publishing obtain, and in this sense they may be said to be part of 
the set of conditions causing or not causing the harmful effects.
For an agent to be morally responsible for certain harmful 
effects, the agent must reasonably be able to foresee these 
effects. Editors are arguably in a very good position with respect 
to foreseeing the potential harmful effects of publishing research 
because:
 ► They understand medical research,
 ► They have insights into the interests of various stakeholders 
and 
 ► They know about the role of different media in the dissem-
ination of research.
Most if not all editors have a background in research and 
therefore must be expected to be able to understand and criti-
cally engage with the content of research publications. And, very 
importantly, they are aided in these efforts by the reviewers, who 
may have a firmer grasp of specific areas within a particular field 
of medical research.
Surely editors also have insight into the interests of researchers 
and research groups, healthcare professionals and organisa-
tions, decision-makers and the wider public as these interests 
are reflected in the ongoing discussions in medical journals and 
in the broader healthcare-related dialogue in the mass media. 
And, most certainly, editors have substantial experience of the 
role of medical journals in the wider dissemination chain from 
researcher to the public. They have seen how scientific studies 
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may get picked up—perhaps distorted or one-sidedly repre-
sented—by mass media and how this may influence public 
opinion and debate, individual behaviour as well as political 
decision-making.
These insights—at least in certain cases—place editor’s in 
a good position in terms of foreseeing the potential harmful 
effects of publishing research.
dismissing the moral responsibility of editors I: benefits of 
publishing and academic freedom
The moral responsibility of editors for such effects may be 
considered negligible for at least two reasons:
1. The benefits of publishing always outweigh the harm it can 
cause.
2. The value of academic freedom outweighs the harm caused.
Certainly most, if not all, research may provide new and 
useful knowledge—at least in the weak sense of leading to the 
evolution of science. It is not, however, self-evidently true that 
these benefits always outweigh the harm caused. The Danish and 
UK studies both yielded novel insights that in turn may lead to 
more effective treatments/less overtreatment, but it is not self-ev-
idently true that these potential benefits outweigh the harm of 
increased microbial multiresistance and the risk of undertreat-
ment of high levels of cholesterol. To determine this requires a 
cost-benefit analysis on a case-by-case basis—it cannot be estab-
lished a priori.
It may be objected that providing an adequate cost-benefit 
analysis is impossible since it requires both an adequate catalogue 
of benefits and harms and an adequate prediction of the course 
of the world following publication of research. The former is not 
readily available and the latter seems unrealistic. However, there 
are no compelling reasons to believe that international or jour-
nal-specific publication ethics codes could not—through open 
and transparent processes involving relevant stakeholders—be 
amended to take into account the potential harmful effects of 
publishing in a way that is adequate for all practical purposes.
The potential benefits of publishing may be claimed to 
outweigh the harms and so may the right to academic freedom. 
Academic freedom may tentatively be defined as the right of 
researchers to freely choose their object and methods of research 
and to communicate their findings to the wider public without 
being censored or sanctioned. Certainly academic freedom is 
valuable. However, it cannot reasonably be thought to be an 
absolute right. As Mill realised, rights to liberty may only be 
exercised to the extent that such exercise do not cause harm 
to others.25 From this viewpoint, it is the risk of harm that 
outweighs academic freedom. The fact that harm may outweigh 
academic freedom is already reflected in international research 
ethics codes such as the Helsinki Declaration.
Most importantly, however, even if we maintain that 1. and 2. 
hold for all cases, it still does not follow that the moral responsi-
bility of editors is negligible. It may at best provide editors with 
a strong case for publishing research, but it does not mean that 
they are not morally responsible for taking steps to minimise or 
entirely avoid the harmful effects. If, on balance, we believe that 
the Danish and UK studies should be published, this does not 
mean that editors and reviewers should not call attention to the 
potential harmful effects of publishing these studies and try to 
avoid or at least mitigate such effects.
dismissing the moral responsibility of editors II: distribution 
of moral responsibility
The moral responsibility of editors may also be considered negli-
gible on the grounds that:
3. The moral responsibility for the harmful effects must be dis-
tributed between several agents
There is a problem of ‘many hands’ in relation to the potential 
harmful effects of publishing research.26 Several other agents—
the researchers, the mass media, the healthcare professionals, 
decision-makers to mention but a few—play a causal role in 
producing harmful effects that could be foreseen by any of them. 
Hence, they all have moral responsibility. The cardinal ques-
tion, therefore, becomes how the moral responsibility should 
be distributed among the relevant agents. What is a reasonable 
distribution of moral responsibility for the harmful effects of 
publishing?
First of all, it should once again be noted that, even if we 
accept 3., it does not entail that editors are not morally respon-
sible or that their moral responsibility is negligible. Second, there 
are good grounds for thinking that editors should be assigned 
responsibility beyond the negligible. Editors are in a good posi-
tion with respect to foreseeing the potential harm of publishing. 
But they are in a unique position with respect to acting on their 
moral responsibility in two ways:
 ► Editors are capable of strongly influencing the reception of 
research.
They can block publication and can also in and through 
the publication process influence both the content of research 
publications and the context of the publication and thereby 
shape the broader reception of the research among the various 
healthcare stakeholders including the research community, 
healthcare professionals and organisations, mass media and deci-
sion-makers. More on this below.
 ► Although editors may have various interests in publishing 
a specific piece of research beside the quality of the study, 
it seems that they would generally be less biased in making 
publishing decisions about the specific research than 
researchers.
Evidently, researchers may also strongly influence what is 
published—and hence may be argued to have moral responsi-
bility for the harmful effects of publishing27–29—but they can 
hardly be expected to serve as impartial judges of the potential 
harmful effects of publishing their research and to act accord-
ingly.11 13 30
should All medICAl ReseARCh be publIshed
The moral responsibility of editors for the harmful effects of 
publishing research may be exercised in different ways. An 
obvious instrument for exercising moral responsibility is to 
deny publication. But is this an adequate instrument? A guiding 
principle in law-making and policy-making is the principle of 
proportionality, which requires of a law or policy (1) that it 
should be an effective way of achieving a desired goal and (2) 
that the goal should be desirable and (3) that there should be no 
less invasive, alternative ways of achieving the same goal.31 The 
proportionality principle thus suggests three criteria for evalu-
ating the adequacy of any instrument of moral responsibility.
Instruments of moral responsibility I: rejection of publication
Denying the publication of research may at first sight seem 
an ineffective instrument for avoiding the harmful effects of 
publishing research. After all, there are numerous both printed 
and online journals in a competitive market, and a multitude 
of online platforms providing access to both the wider research 
community and the public. However, denying publication of a 
paper may still play a regulatory role by ‘cooling off ’ the desire 
to seek publication of a certain type of research. Researchers 
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have various interests. They have an interest in getting their 
research published and to get it published in particularly relevant 
and prestigious scientific journals with rigorous peer review, 
access to a large research community and so forth.14 These 
secondary interests confer on editors the power to influence 
what researchers seek to publish. Moreover, if the rejection of 
publication is based on an internationally adopted of publication 
ethics, then the ‘cooling off ’ effect will gain some impetus, and 
the rejection of publication may be effective in some degree in 
avoiding the harms of publishing. Criteria (1) of the proportion-
ality principle may thus be satisfied, if only partially.
That effectiveness comes at a price. The rejection of publi-
cation by editors may lead to the self-censoring of research by 
researchers. That is, it seems likely that the stronger the ‘cooling 
off ’ effect on the desire to publish a certain type of research, the 
stronger the ‘cooling off ’ effect on the desire to conduct this 
research. After all, why conduct research that one may not be 
able to get published in journals that are considered attractive. 
This will obviously not pose a problem in those cases where the 
research seems unlikely to generate any benefit, but there are 
very few, if any, clear-cut cases of such research. Most medical 
research may be argued to generate insights that eventually will 
benefit patients and society. It seems undeniable that the Danish 
and UK studies provided valuable insights that, if applied in the 
right way, may come to benefit patients. This ultimately goes to 
show that the denial of publication fails as a means to achieving 
what is ultimately the desired goal, namely gaining the benefits 
from publishing research while avoiding the harms. Criteria (2) 
of the proportionality principle is thus only partially satisfied.
Instruments of moral responsibility II: influencing content and 
context of publications
Finally, denying publication fails as an adequate instrument 
because of the availability of alternative instruments that may 
achieve the truly desired goal of avoiding the harmful effects 
while preserving the benefits of publishing research. These alter-
native instrument may even promote academic freedom.
Arguably, the harmful effects following the publication of 
medical research are in many cases due to one-sided communi-
cation of research findings to the various stakeholders as well as 
insufficient regulation of the uses of these findings in research 
and clinical practice. The Danish and UK studies are prototyp-
ical examples of this. The potential harmful effects of publishing 
these studies only obtain if the dissemination of these studies 
leads to undesirable changes in clinical practice or to unsolicited 
changes in patient compliance. Clinical practice may, however, 
be regulated through policy and law, and patient compliance 
may be influenced through information (as the follow-up 
study of the effects of publishing the UK study shows). Thus 
the harmful effects of publishing these studies may to a large 
extent be avoided if the relevant clinical practices become prop-
erly regulated and if the public is provided with balanced and 
rounded information. If so, then certainly there is a pivotal role 
for editors to play in avoiding the harmful effects of publishing. 
They may raise awareness of the potential harmful effects of 
publishing research and of the need for proper regulation and 
they may take steps to ensure balanced information to all rele-
vant stakeholders. And they are in unique position to do so, as 
they may influence both the content and the context of research 
publications.
Editors may influence the content of publications with the 
aim of avoiding harmful effects in a variety of ways. They may 
require authors to explicitly describe and address the potential 
harmful effects and the need for regulation, and they may ask 
authors to revise unnecessarily strong, one-sided, unbalanced 
statements that are likely to be picked up and communicated 
uncritically by the mass media.
Editors may also influence the context of publications by 
inviting reviewer or open peer comments or by an editorial 
comment. They may choose to include such research in special 
thematic issues with a special emphasis on the wider effects 
of publishing this research. They may highlight the sensitive 
issues in their advertising on social media and in potential 
press releases to the mass media. They could even ask a panel 
of healthcare organisations and relevant decision-makers to 
comment in the journal on the potential harmful effects and 
the need for regulation. The dampening effect on the moti-
vation to conduct valuable research would presumably be 
non-existent or very small. The wider implication being that 
the denial of publication also fails to satisfy criteria (3) of the 
proportionality principle.
policy implications
The previous arguments have provided a basis for suggesting 
that publication ethics codes should:
1. Acknowledge moral responsibility for the effects of 
publishing.
2. Define benefits and harms of publishing.
3. Specify a range of actions an editor may take.
An internationally adopted and enforced code of publication 
ethics with these elements would serve as a guide for editors 
and thus secure consistency in the relevant editorial decisions. It 
would also be an important step towards creating transparency 
and thus underpinning accountability in such decisions.
Could such a code of publication ethics reasonably be jour-
nal-specific? Could each medical journal make up its own stan-
dards and sanctions? Needless to say, the preventive effect would 
be limited, and it would generate uncertainty among researchers 
about submission requirements. Hence, there are good grounds 
for seeking an international code of publication ethics with the 
suggested elements.
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